Recent Updates
Recently added Catalysts
FEED Positive Sentiment

Marc Waldman

Key Takeaway: Marc Waldman brings over 35 years of experience in the medical device sector, notably increasing revenue at Avanos Medical. He has held various leadership roles and is currently the Chairperson of GEDSA, focusing on improving enteral safety standards in healthcare. His career reflects a strong commitment to maternal-child health and innovation in medical devices.
Price reaction · baseline $1.31 (2026-01-16 close) · hit pre-market · 4 other FEED headline(s) in the window, move may be shared
day 0 close
-6.1%
day 1
-3.8%
day 3 · peak
-16%

Market Sentiment Analysis

POSITIVE FACTORS

  • Marc Waldman has extensive experience in the medical device industry.
  • He successfully grew revenue significantly at Avanos Medical.
  • He is actively involved in advancing enteral safety standards.

Full Press Release Details

Marc Waldman has over 35 years of experience in the medical device industry, including nearly a decade with NeoMed and Avanos Medical, where he served as North America Sales Director for the neonatal enteral feeding portfolio. In this role, he led a national team, expanded key accounts, guided a transition to a hybrid direct/dealer model, and grew revenue from approximately $39M to $70M in three and a half years.
Previously, Marc was Principal of West Branch Medical, helping build it into a multimillion-dollar maternal-child health distributor, and held commercial leadership roles at Wren Medical, NOW Medical, Day & Zimmermann, and Vital Signs.
He currently serves as Chairperson of GEDSA, advancing enteral safety standards across the U.S. healthcare system.

Frequently Asked Questions

What is Marc Waldman's experience in the medical device industry?

Marc Waldman has over 35 years of experience in the medical device industry.

What role did Marc Waldman hold at Avanos Medical?

He served as North America Sales Director for the neonatal enteral feeding portfolio.

What is GEDSA and what is Marc Waldman's role?

GEDSA focuses on advancing enteral safety standards, and Marc serves as Chairperson.

How much did revenue grow during Waldman's tenure at Avanos?

Revenue grew from approximately $39M to $70M in three and a half years.

Last updated: Jan 20, 2026